Catalyst Wire Dossier Catalyst Wire Dossier

Eloralintide

LY3841136 · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Eloralintide, covering 2025-11-19 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes [Phase 3]

See pricing